The Health Foundation, London, UK.
Department of Health Policy, London School of Economics and Political Science, London, UK.
Nat Cancer. 2020 Jun;1(6):565-567. doi: 10.1038/s43018-020-0074-y.
The COVID-19 pandemic has disrupted the spectrum of cancer care, including delaying diagnoses and treatment and halting clinical trials. In response, healthcare systems are rapidly reorganizing cancer services to ensure that patients continue to receive essential care while minimizing exposure to SARS-CoV-2 infection.
新型冠状病毒肺炎疫情打乱了癌症治疗的范围,包括延迟诊断和治疗以及停止临床试验。为此,医疗保健系统正在迅速调整癌症服务,以确保患者在尽量减少感染严重急性呼吸综合征冠状病毒 2 型的情况下继续获得基本护理。